Post-IPO Debt - Sareum Holdings PLC
Investment Firm
Overview
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer
Announced Date
Aug 03, 2023
Funding Type
Post Ipo Debt
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Sareum Holdings PLC raised $2543135 on 2023-08-03 in Post-IPO Debt
Sareum is a drug discovery company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 03, 2021 |  Post-IPO Equity - Sareum Holdings PLC | - | 1.3M | |
| Aug 03, 2023 | Post-IPO Debt - Sareum Holdings PLC | 1 | - | 2.5M |
Recent Activity
There is no recent news or activity for this profile.